📢 Calling all aspiring professionals and public servants! NIAID has opportunities for everyone, from researcher positions to administrative and support staff. View our open career opportunities at go.nih.gov/9ErUr1a #Recruitment #CareerOpportunity #JoinOurTeam #PSRW

On #WorldAsthmaDay , check out this novel telemedicine program that holds promise for improved follow-up and preventive care in children after an emergency department visit for #asthma . go.nih.gov/o3iNgUb Breathe Better

Today on #WorldAsthmaDay , NIAID reaffirms its commitment to reducing illness and death from this chronic lung disease and improving quality of life through research that informs the development of new #asthma prevention and treatment strategies: go.nih.gov/dKmnHYT

Two recent publications explore why some people hospitalized with #COVID19 fare better than others. Learn more at go.nih.gov/OtaSwaz

#NIAID scientists developed a new tool that could help identify geographic hot spots for Aedes mosquitoes, which can spread diseases such as #dengue and #Zika , using a marker from blood serum of people bitten by the mosquitoes. Learn more at go.nih.gov/56xP8La

A dose-sparing #mpox #vaccine regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks in a #NIAID -sponsored study presented at #ESCMIDGlobal2024 . Learn more: go.nih.gov/w2KFNpC NIH

#NIH

Experimental NIAID #malaria #monoclonal antibody protective in Malian children. Phase 2 trial shows treatment prevents infection, disease. go.nih.gov/s7Nrrhl

Making data from #LongCOVID studies broadly available can increase our understanding & lead to scientific advances that improve people’s lives. Now, some #NIHRECOVER Adult Cohort Study data are available in the #BioDataCatalyst ecosystem. recovercovid.org/data David Goff, MD, PhD

On #WorldMalariaDay , NIAID renews its commitment to finding new ways to combat malaria-causing mosquitoes and developing innovative malaria diagnostics, treatments in the face of growing drug resistance, and vaccines. go.nih.gov/2yGxFJe

📅 Last chance to register!

Attend OAR’s Workshop for Early Career Investigators in #HIV to learn about the #NIH #HIV research program, grant application and peer review process, and resources for new investigators. Register: go.nih.gov/oareciworkshop…

#EarlyCareerInvestigator

VIDEO: #NIAID Director Jeanne Marrazzo, M.D., M.P.H. and NIAID-funded scientists discuss the importance and experience of early-stage #HIV investigators. Click the link to our video to learn more: youtube.com/watch?v=9FZEe3…

The next generation of leaders will be central to advancing #HIV science. #NIAID wants to fund more early-stage HIV investigators and has special programs and funding approaches to meet that goal. Learn more: go.nih.gov/yuCfiNm

To combat deadly #meningitis outbreaks, Nigeria launched an effort to vaccinate 1 million people with a vaccine that protects against 5 types of meningitis. WHO recommended the vaccine based partly on positive interim results from a #NIAID -supported trial who.int/news/item/12-0…

Did you know #chlamydia was the most reported bacterial sexually transmitted infection (STI) in the U.S. in 2022 according to CDC? NIAID supports research on treatment options and preventive vaccine development. Learn more: go.nih.gov/xeBi0eI

#STIWeek

Herpes is an STI caused by herpes simplex virus type 1 or type 2. In 2023, the Strategic Plan for Herpes Simplex Virus Research was created to advance understanding of HSV virology & accelerate development of diagnostics, vaccines, & therapies: go.nih.gov/LaA0MY7 #STIWeek

Funding News niaid.nih.gov/grants-contrac…. Learn about the FORMS-I transition, acknowledging NIH support, success rates and the NIH budget, new opportunities, and more!

Human papillomavirus ( #HPV ) is the most common sexually transmitted infection in the US & often has no symptoms. NIAID conducts & supports research to better understand papillomaviruses, develop new diagnostics, & find new treatments. Learn more: go.nih.gov/74zY8mt #STIWeek

#NIAID supports research to develop effective diagnostic, preventive and therapeutic #SexuallyTransmittedInfection (STI) interventions. Learn about new projects and recent advances in #STI research: go.nih.gov/QhJXX9Q

#STI Week

A #NIAID -sponsored study found #HepatitisE #vaccine , HEV-239, was safe and achieved a durable immune response among healthy adults. There is no preventive vaccine for hepatitis E in the U.S., which causes about 70,000 deaths globally per year.
Learn more: doi.org/10.1093/infdis…